These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study. Monet-Didailler C, Chevallier A, Godron-Dubrasquet A, Allard L, Delmas Y, Contin-Bordes C, Brissaud O, Llanas B, Harambat J. Nephrol Dial Transplant; 2020 Dec 04; 35(12):2147-2153. PubMed ID: 31411695 [Abstract] [Full Text] [Related]
9. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland. Bai X, Ylinen E, Zhang J, Salmenlinna S, Halkilahti J, Saxen H, Narayanan A, Jahnukainen T, Matussek A. Microbiol Spectr; 2022 Aug 31; 10(4):e0066022. PubMed ID: 35730965 [Abstract] [Full Text] [Related]
10. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome. Walsh PR, Johnson S. Pediatr Nephrol; 2019 Sep 31; 34(9):1485-1492. PubMed ID: 30058046 [Abstract] [Full Text] [Related]
16. Hemolytic uremic syndrome in children. Talarico V, Aloe M, Monzani A, Miniero R, Bona G. Minerva Pediatr; 2016 Dec 17; 68(6):441-455. PubMed ID: 27768015 [Abstract] [Full Text] [Related]
17. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS). Caillaud C, Zaloszyc A, Licht C, Pichault V, Frémeaux-Bacchi V, Fischbach M. Pediatr Nephrol; 2016 Jan 17; 31(1):157-61. PubMed ID: 26399238 [Abstract] [Full Text] [Related]
20. Is eculizumab efficacious in Shigatoxin-associated hemolytic uremic syndrome? A narrative review of current evidence. Keenswijk W, Raes A, Vande Walle J. Eur J Pediatr; 2018 Mar 17; 177(3):311-318. PubMed ID: 29288280 [Abstract] [Full Text] [Related] Page: [Next] [New Search]